ESC 365 - undefined undefined undefined

Speaker illustration

undefined undefined undefined

Presentations Articles

One-year outcomes of patients with hypertrophic cardiomyopathy according to levels of inflammatory biomarkers

Event: ESC Congress 2024

Topic: Hypertrophic Cardiomyopathy

Session: Hypertrophic cardiomyopathy: risk prediction and outcomes

Effects of anakinra on patients with heart failure below and above 60 years of age

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Heart failure therapy: new insights

Real-life experience with rilonacept for the treatment of recurrent pericarditis

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Acute and chronic pericarditis: how to best manage your patients

Differential response to interleukin-1 blockade with anakinra on cardiorespiratory fitness in patients with heart failure with preserved ejection fraction stratified according to ejection fraction

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Pharmacological therapy in heart failure (1)

A case of Platypnea-Orthodeoxia syndrome: diagnosis by exclusion or something to look for?

Event: ESC Congress 2019

Topic: Clinical

Session: Challenging clinical cases

Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate

Event: ESC Congress 2017

Topic: Microcirculation and collaterals

Session: Coronary microcirculation

ESC 365 is supported by

novartis

Explore sponsored resources